Body Composition Analyzers Market – Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Product (Bio-impedance Analyzer, Skinfold Callipers, Hydrostatic Weighing Equipment, Air Displacement Plethysmography, Dual Energy X-ray Absorptiometry, Other), By End-User (Hospitals, Fitness Clubs and Wellness Centers, Academic and Research Centers, Other), By Region & Competition, 2021-2031F

May 2026 | 185 pages | ID: B0A230A6107FEN
TechSci Research

Abstracts

The Global Body Composition Analyzers Market is projected to expand significantly, growing from USD 739.32 Million in 2025 to USD 1195.54 Million by 2031, at an impressive Compound Annual Growth Rate (CAGR) of 8.34%. These medical assessment devices are specifically designed to precisely quantify physiological components like fat mass, lean muscle tissue, and visceral water content, primarily utilizing advanced techniques such as bioelectrical impedance analysis or dual-energy X-ray absorptiometry. This market's fundamental growth is propelled by the escalating global incidence of obesity and metabolic disorders, which critically demand accurate monitoring tools for effective clinical interventions and sustained health management. Additionally, the growing geriatric population and the increasing adoption of professional health monitoring protocols within non-clinical wellness centers further contribute to the sustained demand for these crucial diagnostic systems. One notable challenge impeding broader market expansion, however, is the substantial capital investment required for professional-grade devices. This financial barrier limits their adoption in healthcare settings with limited resources and smaller medical practices. Despite this, the market holds immense potential; the World Obesity Federation projected in 2025 that the global adult population living with obesity would reach 1.13 billion by 2030. This projection highlights a considerably expanding addressable market for body composition analysis, emphasizing the urgent need for precise diagnostic solutions to effectively manage weight-related public health concerns.

Market Driver

The rising global prevalence of obesity and metabolic disorders serves as a primary driver for the increased adoption of body composition analyzers in medical and clinical environments. Healthcare providers are progressively shifting from basic weight measurement to comprehensive body composition analysis to accurately diagnose and manage conditions such as type 2 diabetes and cardiovascular disease. This crucial clinical paradigm shift is underscored by the pressing need for intervention, as evidenced by the World Obesity Federation's 'World Obesity Atlas 2025' report from March 2025, which indicated that overweight and obesity annually contribute to 1.6 million premature deaths from non-communicable diseases. Consequently, hospitals and specialized clinics are making substantial investments in high-precision analyzers to meticulously monitor visceral fat and muscle mass, thereby enabling the development of more targeted therapeutic strategies for high-risk patient populations. Concurrently, the rapid growth of the fitness, health club, and wellness center industry is significantly bolstering market expansion, as these facilities differentiate their services through the integration of professional-grade diagnostics. Gyms and rehabilitation centers are now leveraging these devices to offer members tangible metrics on muscle gain and fat loss, which directly enhances member retention and the perceived value of their services. This robust commercial demand for fitness services necessitating such equipment is reflected in Planet Fitness, Inc.'s 'Third Quarter 2025 Results' from November 2025, reporting a 13.0% increase in total revenue to $330.3 million. Furthermore, a broader consumer trend toward performance monitoring is evident; Garmin Ltd. reported a 30% increase in revenue from its fitness segment in the third quarter of 2025, signaling a heightened consumer appetite for personal body monitoring technologies.

Market Challenge

A significant constraint on market expansion is the substantial capital investment required for professional-grade body composition analyzers, which particularly affects independent medical practices and community clinics. These advanced diagnostic systems entail considerable upfront costs that often surpass the immediate financial returns for smaller facilities operating with tight budgetary constraints. As a result, healthcare providers with limited resources frequently prioritize essential operational expenses over the acquisition of advanced assessment tools, effectively narrowing the potential customer base to larger, well-funded institutions. This economic impediment thus hinders the widespread adoption crucial for robust market growth. Further illustrating this challenge, the American Hospital Association reported in 2025 that 94% of healthcare administrators anticipated delaying equipment upgrades due to financial strain. This statistic directly demonstrates the correlation between budgetary pressures and the deferral of capital equipment purchases. When medical facilities face fiscal uncertainty, the procurement of non-emergency diagnostic technologies, such as body composition analyzers, is often among the first expenditures to be postponed. This reluctance to invest in new capital equipment creates a stagnant sales environment, directly impeding the broader integration of these essential devices into the global healthcare infrastructure.

Market Trends

The integration of Artificial Intelligence (AI) for Predictive Health Analytics is fundamentally transforming the market, evolving devices from mere measurement tools into sophisticated prognostic engines. Manufacturers are leveraging extensive datasets to train advanced algorithms capable of identifying subtle physiological patterns, thereby enabling the prediction of health risks like sarcopenia or visceral fat accumulation long before clinical symptoms become apparent. This innovative capability facilitates personalized intervention strategies, significantly enhancing the utility of these systems in the realm of preventive medicine. For instance, InBody Co., Ltd., in its '2024 InBody Report' from February 2024, highlighted how it utilized its cloud database, comprising over 100 million global body composition data points, to derive novel medical insights, including the identification of regional health disparities such as lean obesity rates. Concurrently, the proliferation of portable and home-use diagnostic devices is democratizing access to body composition monitoring, fundamentally shifting the primary point of care from traditional hospital settings to residential environments. This notable trend is fueled by the ongoing miniaturization of bioelectrical impedance analysis sensors, which are increasingly being integrated into consumer-grade smart scales and handheld monitors, providing users with continuous insight into their physiological status. This rapidly expanding consumer segment has emerged as a significant revenue stream for major medical device manufacturers. Omron Corporation, for example, noted in its 'Integrated Report 2024' from September 2024 that sales of body composition monitors accounted for 4% of its Healthcare Business division's total revenue of 145.9 billion yen, underscoring the strong commercial demand for these personal health management tools.

Key Market Players

• Bodystat Ltd
• Cosmed S.R.L
• Hologic Inc.
• Inbody Co. Ltd
• Maltron International Ltd
• Omron Healthcare Inc.
• Seca GmbH & Co. Kg
• Tanita Corporation
• Fitbit Inc.
• Koninklijke Philips NV
• EatSmart Inc.

Report Scope

In this report, the Global Body Composition Analyzers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Body Composition Analyzers Market, By Product
• Bio-impedance Analyzer
• Skinfold Callipers
• Hydrostatic Weighing Equipment
• Air Displacement Plethysmography
• Dual Energy X-ray Absorptiometry
• Other
• Body Composition Analyzers Market, By End-User
• Hospitals
• Fitness Clubs and Wellness Centers
• Academic and Research Centers
• Other
• Body Composition Analyzers Market, By Region
• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Body Composition Analyzers Market.

Available Customizations:

Global Body Composition Analyzers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL BODY COMPOSITION ANALYZERS MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Product (Bio-impedance Analyzer, Skinfold Callipers, Hydrostatic Weighing Equipment, Air Displacement Plethysmography, Dual Energy X-ray Absorptiometry, Other)
  5.2.2. By End-User (Hospitals, Fitness Clubs and Wellness Centers, Academic and Research Centers, Other)
  5.2.3. By Region
  5.2.4. By Company (2025)
5.3. Market Map

6. NORTH AMERICA BODY COMPOSITION ANALYZERS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Product
  6.2.2. By End-User
  6.2.3. By Country
6.3. North America: Country Analysis
  6.3.1. United States Body Composition Analyzers Market Outlook
    6.3.1.1. Market Size & Forecast
      6.3.1.1.1. By Value
    6.3.1.2. Market Share & Forecast
      6.3.1.2.1. By Product
      6.3.1.2.2. By End-User
  6.3.2. Canada Body Composition Analyzers Market Outlook
    6.3.2.1. Market Size & Forecast
      6.3.2.1.1. By Value
    6.3.2.2. Market Share & Forecast
      6.3.2.2.1. By Product
      6.3.2.2.2. By End-User
  6.3.3. Mexico Body Composition Analyzers Market Outlook
    6.3.3.1. Market Size & Forecast
      6.3.3.1.1. By Value
    6.3.3.2. Market Share & Forecast
      6.3.3.2.1. By Product
      6.3.3.2.2. By End-User

7. EUROPE BODY COMPOSITION ANALYZERS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By End-User
  7.2.3. By Country
7.3. Europe: Country Analysis
  7.3.1. Germany Body Composition Analyzers Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By End-User
  7.3.2. France Body Composition Analyzers Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By End-User
  7.3.3. United Kingdom Body Composition Analyzers Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By End-User
  7.3.4. Italy Body Composition Analyzers Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Product
      7.3.4.2.2. By End-User
  7.3.5. Spain Body Composition Analyzers Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Product
      7.3.5.2.2. By End-User

8. ASIA PACIFIC BODY COMPOSITION ANALYZERS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By End-User
  8.2.3. By Country
8.3. Asia Pacific: Country Analysis
  8.3.1. China Body Composition Analyzers Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product
      8.3.1.2.2. By End-User
  8.3.2. India Body Composition Analyzers Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product
      8.3.2.2.2. By End-User
  8.3.3. Japan Body Composition Analyzers Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product
      8.3.3.2.2. By End-User
  8.3.4. South Korea Body Composition Analyzers Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product
      8.3.4.2.2. By End-User
  8.3.5. Australia Body Composition Analyzers Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product
      8.3.5.2.2. By End-User

9. MIDDLE EAST & AFRICA BODY COMPOSITION ANALYZERS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By End-User
  9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
  9.3.1. Saudi Arabia Body Composition Analyzers Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product
      9.3.1.2.2. By End-User
  9.3.2. UAE Body Composition Analyzers Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product
      9.3.2.2.2. By End-User
  9.3.3. South Africa Body Composition Analyzers Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product
      9.3.3.2.2. By End-User

10. SOUTH AMERICA BODY COMPOSITION ANALYZERS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Product
  10.2.2. By End-User
  10.2.3. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Body Composition Analyzers Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product
      10.3.1.2.2. By End-User
  10.3.2. Colombia Body Composition Analyzers Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product
      10.3.2.2.2. By End-User
  10.3.3. Argentina Body Composition Analyzers Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product
      10.3.3.2.2. By End-User

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. GLOBAL BODY COMPOSITION ANALYZERS MARKET: SWOT ANALYSIS

14. PORTER'S FIVE FORCES ANALYSIS

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. COMPETITIVE LANDSCAPE

15.1. Bodystat Ltd
  15.1.1. Business Overview
  15.1.2. Products & Services
  15.1.3. Recent Developments
  15.1.4. Key Personnel
  15.1.5. SWOT Analysis
15.2. Cosmed S.R.L
15.3. Hologic Inc.
15.4. Inbody Co. Ltd
15.5. Maltron International Ltd
15.6. Omron Healthcare Inc.
15.7. Seca GmbH & Co. Kg
15.8. Tanita Corporation
15.9. Fitbit Inc.
15.10. Koninklijke Philips NV
15.11. EatSmart Inc.

16. STRATEGIC RECOMMENDATIONS

17. ABOUT US & DISCLAIMER